KR20020010631A - 신규 화합물 - Google Patents
신규 화합물 Download PDFInfo
- Publication number
- KR20020010631A KR20020010631A KR1020017014014A KR20017014014A KR20020010631A KR 20020010631 A KR20020010631 A KR 20020010631A KR 1020017014014 A KR1020017014014 A KR 1020017014014A KR 20017014014 A KR20017014014 A KR 20017014014A KR 20020010631 A KR20020010631 A KR 20020010631A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- alkyl
- compound
- amino
- tert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/09—Diamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901572-9 | 1999-05-03 | ||
| SE9901572A SE9901572D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
| PCT/SE2000/000846 WO2000066550A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20020010631A true KR20020010631A (ko) | 2002-02-04 |
Family
ID=20415425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020017014014A Withdrawn KR20020010631A (ko) | 1999-05-03 | 2000-05-03 | 신규 화합물 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7354895B1 (enExample) |
| EP (1) | EP1180099A1 (enExample) |
| JP (1) | JP4270759B2 (enExample) |
| KR (1) | KR20020010631A (enExample) |
| CN (1) | CN1358187A (enExample) |
| AR (1) | AR028826A1 (enExample) |
| AU (1) | AU4447100A (enExample) |
| BR (1) | BR0010256A (enExample) |
| CA (1) | CA2371215A1 (enExample) |
| CZ (1) | CZ20013931A3 (enExample) |
| EE (1) | EE200100573A (enExample) |
| HK (1) | HK1042493A1 (enExample) |
| HU (1) | HUP0202379A3 (enExample) |
| IL (1) | IL145953A0 (enExample) |
| IS (1) | IS6141A (enExample) |
| MX (1) | MXPA01011043A (enExample) |
| NO (1) | NO20015374L (enExample) |
| PL (1) | PL356140A1 (enExample) |
| SE (1) | SE9901572D0 (enExample) |
| SK (1) | SK15662001A3 (enExample) |
| TR (1) | TR200103144T2 (enExample) |
| WO (1) | WO2000066550A1 (enExample) |
| ZA (2) | ZA200108967B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0014615A (pt) * | 1999-09-14 | 2002-06-18 | Meiji Seika Kaisha | Derivado de ácido fosfÈnico que apresenta atividade inibidora contra carboxipeptidase b |
| HRP20030103A2 (en) * | 2000-08-17 | 2003-04-30 | Pfizer | Substituted imidazoles as tafia inhibitors |
| SE0103272D0 (sv) * | 2001-09-28 | 2001-09-28 | Astrazeneca Ab | Chemical compounds |
| US6713496B2 (en) | 2002-01-22 | 2004-03-30 | Pfizer Inc | 3-(imidazolyl)-2-alkoxypropanoic acids |
| IL162677A0 (en) * | 2002-01-22 | 2005-11-20 | Pfizer | 3-(Imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| MXPA04005940A (es) | 2002-01-22 | 2004-09-13 | Pfizer | Acidos 3-(imidazolil)-2-aminopropanoicos. |
| EP2204373A1 (en) | 2002-03-21 | 2010-07-07 | Bayer Schering Pharma Aktiengesellschaft | Phosphonic acid as Plasma Carboxypeptidase B Inhibitors |
| JPWO2010050525A1 (ja) | 2008-10-29 | 2012-03-29 | 大正製薬株式会社 | ＴＡＦＩａ阻害活性を有する化合物 |
| IL285108B2 (en) * | 2019-02-08 | 2024-10-01 | Astrazeneca Ab | Arginase inhibitors and methods of use thereof |
| CN111110837B (zh) * | 2020-01-06 | 2022-11-25 | 中国人民解放军陆军军医大学 | 一种羧肽酶抑制剂在制备预防重症致死性轮状病毒感染药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2516307A (en) * | 1949-01-06 | 1950-07-25 | Gen Mills Inc | Vinyl resins plasticized with cyano esters |
| US4560680A (en) * | 1982-03-15 | 1985-12-24 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
| US4849414A (en) * | 1986-06-11 | 1989-07-18 | E. R. Squibb & Sons, Inc. | Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors |
| FR2610951B1 (fr) * | 1987-02-17 | 1989-05-05 | Aerospatiale | Armature tissee pour materiau composite |
| IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
| NZ246456A (en) * | 1991-12-17 | 1997-03-24 | Procter & Gamble Pharma | Use of bone active phosphonate and a parathyroid hormone to prepare medicaments for a thirty day treatment regimen for osteoporosis |
| US5550119A (en) * | 1995-03-02 | 1996-08-27 | Ciba-Geigy Corporation | Phosphono substituted tetrazole derivatives as ECE inhibitors |
| US5672592A (en) * | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
| JP3440305B2 (ja) * | 1997-04-02 | 2003-08-25 | 高砂香料工業株式会社 | ７−（ｎ−置換アミノ）−２−フェニルヘプタン酸 エステル誘導体及び該誘導体の製造方法 |
| UA58543C2 (uk) | 1997-02-27 | 2003-08-15 | Амерікан Ціанамід Компані | N-гідрокси-2-(алкіл-, арил-, або гетероарилсульфаніл, -сульфініл або -сульфоніл)-3-заміщені алкіл-, арил- або гетероариламіди як інгібітори матричних металопротеїназ |
| AR023819A1 (es) * | 1999-05-03 | 2002-09-04 | Astrazeneca Ab | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
| SE9901573D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
| BR0014615A (pt) * | 1999-09-14 | 2002-06-18 | Meiji Seika Kaisha | Derivado de ácido fosfÈnico que apresenta atividade inibidora contra carboxipeptidase b |
-
1999
- 1999-05-03 SE SE9901572A patent/SE9901572D0/xx unknown
-
2000
- 2000-04-28 AR ARP000102082A patent/AR028826A1/es not_active Application Discontinuation
- 2000-05-03 US US09/600,660 patent/US7354895B1/en not_active Expired - Fee Related
- 2000-05-03 CA CA002371215A patent/CA2371215A1/en not_active Abandoned
- 2000-05-03 JP JP2000615381A patent/JP4270759B2/ja not_active Expired - Fee Related
- 2000-05-03 KR KR1020017014014A patent/KR20020010631A/ko not_active Withdrawn
- 2000-05-03 HU HU0202379A patent/HUP0202379A3/hu unknown
- 2000-05-03 CN CN00809484A patent/CN1358187A/zh active Pending
- 2000-05-03 TR TR2001/03144T patent/TR200103144T2/xx unknown
- 2000-05-03 EE EEP200100573A patent/EE200100573A/xx unknown
- 2000-05-03 MX MXPA01011043A patent/MXPA01011043A/es unknown
- 2000-05-03 BR BR0010256-3A patent/BR0010256A/pt not_active Application Discontinuation
- 2000-05-03 AU AU44471/00A patent/AU4447100A/en not_active Abandoned
- 2000-05-03 IL IL14595300A patent/IL145953A0/xx unknown
- 2000-05-03 CZ CZ20013931A patent/CZ20013931A3/cs unknown
- 2000-05-03 EP EP00925844A patent/EP1180099A1/en not_active Ceased
- 2000-05-03 PL PL00356140A patent/PL356140A1/xx not_active Application Discontinuation
- 2000-05-03 HK HK02104304.1A patent/HK1042493A1/zh unknown
- 2000-05-03 WO PCT/SE2000/000846 patent/WO2000066550A1/en not_active Ceased
- 2000-05-03 SK SK1566-2001A patent/SK15662001A3/sk unknown
-
2001
- 2001-10-30 ZA ZA200108967A patent/ZA200108967B/en unknown
- 2001-10-30 ZA ZA200108966A patent/ZA200108966B/en unknown
- 2001-11-01 IS IS6141A patent/IS6141A/is unknown
- 2001-11-02 NO NO20015374A patent/NO20015374L/no not_active Application Discontinuation
-
2005
- 2005-12-02 US US11/293,060 patent/US7423012B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO20015374D0 (no) | 2001-11-02 |
| CZ20013931A3 (cs) | 2002-04-17 |
| MXPA01011043A (es) | 2002-06-04 |
| JP4270759B2 (ja) | 2009-06-03 |
| US7354895B1 (en) | 2008-04-08 |
| SE9901572D0 (sv) | 1999-05-03 |
| SK15662001A3 (sk) | 2002-09-10 |
| HK1042493A1 (zh) | 2002-08-16 |
| IL145953A0 (en) | 2002-11-10 |
| IS6141A (is) | 2001-11-01 |
| BR0010256A (pt) | 2002-02-13 |
| NO20015374L (no) | 2001-11-02 |
| WO2000066550A1 (en) | 2000-11-09 |
| US20060079484A1 (en) | 2006-04-13 |
| JP2002543179A (ja) | 2002-12-17 |
| CN1358187A (zh) | 2002-07-10 |
| EP1180099A1 (en) | 2002-02-20 |
| ZA200108966B (en) | 2003-01-30 |
| PL356140A1 (en) | 2004-06-14 |
| AU4447100A (en) | 2000-11-17 |
| CA2371215A1 (en) | 2000-11-09 |
| HUP0202379A2 (hu) | 2002-12-28 |
| EE200100573A (et) | 2003-02-17 |
| US7423012B2 (en) | 2008-09-09 |
| AR028826A1 (es) | 2003-05-28 |
| ZA200108967B (en) | 2003-01-30 |
| TR200103144T2 (tr) | 2004-11-22 |
| WO2000066550A8 (en) | 2001-01-25 |
| HUP0202379A3 (en) | 2003-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100755152B1 (ko) | 신규 화합물 | |
| US20070254916A1 (en) | Aryl and heteroaryl compounds, compositions, and methods of use | |
| WO1997046577A1 (en) | New amino acid derivatives and their use as thrombin inhibitors | |
| EP1036061B1 (en) | New compounds | |
| KR100347646B1 (ko) | 매트릭스메탈로프로테아제억제제 | |
| KR20020010631A (ko) | 신규 화합물 | |
| US6737416B2 (en) | Phosphonic acid derivative having inhibitory activity against carboxypeptidase B | |
| KR20020081465A (ko) | 헤테로시클릭 측쇄 함유, ｎ-치환된 메탈로프로테아제저해제 | |
| EP2204373A1 (en) | Phosphonic acid as Plasma Carboxypeptidase B Inhibitors | |
| KR100483869B1 (ko) | 신규한 아미노산 유도체 및 트롬빈 억제제로서의 그의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20011102 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |